{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:49:49Z","timestamp":1792673389337,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A6C101A390"],"award-info":[{"award-number":["2021R1A6C101A390"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2023-00304637"],"award-info":[{"award-number":["RS-2023-00304637"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32334-x","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T08:43:32Z","timestamp":1766652212000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prostate cancer diagnosis using sensitive and sophisticated machine learning classifiers based on non-invasive urinary RNA biomarkers (PCASSO)"],"prefix":"10.1038","volume":"16","author":[{"given":"Hyunseop","family":"Goh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeyang","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bumjin","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Kyun","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan Yong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choung-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"32334_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7\u201330. https:\/\/doi.org\/10.3322\/caac.21590 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"32334_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.eururo.2010.10.039","volume":"59","author":"A Heidenreich","year":"2011","unstructured":"Heidenreich, A. et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur. Urol. 59, 61\u201371. https:\/\/doi.org\/10.1016\/j.eururo.2010.10.039 (2011).","journal-title":"Eur. Urol."},{"key":"32334_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3322\/caac.20066","volume":"60","author":"AM Wolf","year":"2010","unstructured":"Wolf, A. M. et al. American Cancer Society guideline for the early detection of prostate cancer: Update 2010. CA Cancer J. Clin. 60, 70\u201398. https:\/\/doi.org\/10.3322\/caac.20066 (2010).","journal-title":"CA Cancer J. Clin."},{"key":"32334_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1200\/JCO.2009.24.2180","volume":"28","author":"L Klotz","year":"2010","unstructured":"Klotz, L. et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J. Clin. Oncol. 28, 126\u2013131. https:\/\/doi.org\/10.1200\/JCO.2009.24.2180 (2010).","journal-title":"J. Clin. Oncol."},{"key":"32334_CR5","doi-asserted-by":"publisher","first-page":"127rv123","DOI":"10.1126\/scitranslmed.3003180","volume":"4","author":"JR Prensner","year":"2012","unstructured":"Prensner, J. R., Rubin, M. A., Wei, J. T. & Chinnaiyan, A. M. Beyond PSA: The next generation of prostate cancer biomarkers. Sci. Transl. Med. 4, 127rv123. https:\/\/doi.org\/10.1126\/scitranslmed.3003180 (2012).","journal-title":"Sci. Transl. Med."},{"key":"32334_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41391-019-0127-4","volume":"22","author":"JN Eskra","year":"2019","unstructured":"Eskra, J. N., Rabizadeh, D., Pavlovich, C. P., Catalona, W. J. & Luo, J. Approaches to urinary detection of prostate cancer. Prostate Cancer Prostatic Dis. 22, 362\u2013381. https:\/\/doi.org\/10.1038\/s41391-019-0127-4 (2019).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"32334_CR7","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.18632\/oncotarget.2691","volume":"5","author":"F Wang","year":"2014","unstructured":"Wang, F. et al. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer. Oncotarget 5, 11091\u201311102. https:\/\/doi.org\/10.18632\/oncotarget.2691 (2014).","journal-title":"Oncotarget"},{"key":"32334_CR8","doi-asserted-by":"publisher","first-page":"e12806","DOI":"10.1097\/MD.0000000000012806","volume":"97","author":"Z Mao","year":"2018","unstructured":"Mao, Z. et al. Diagnostic performance of PCA3 and hK2 in combination with serum PSA for prostate cancer. Medicine (Baltimore) 97, e12806. https:\/\/doi.org\/10.1097\/MD.0000000000012806 (2018).","journal-title":"Medicine (Baltimore)"},{"key":"32334_CR9","doi-asserted-by":"publisher","first-page":"30722","DOI":"10.1038\/srep30722","volume":"6","author":"KM Koo","year":"2016","unstructured":"Koo, K. M., Wee, E. J., Mainwaring, P. N. & Trau, M. A simple, rapid, low-cost technique for naked-eye detection of urine-isolated TMPRSS2: ERG gene fusion RNA. Sci. Rep. 6, 30722. https:\/\/doi.org\/10.1038\/srep30722 (2016).","journal-title":"Sci. Rep."},{"key":"32334_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.eururo.2015.12.054","volume":"70","author":"L Fabris","year":"2016","unstructured":"Fabris, L. et al. The potential of microRNAs as prostate cancer biomarkers. Eur. Urol. 70, 312\u2013322. https:\/\/doi.org\/10.1016\/j.eururo.2015.12.054 (2016).","journal-title":"Eur. Urol."},{"key":"32334_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14133157","author":"J Juracek","year":"2022","unstructured":"Juracek, J., Madrzyk, M., Stanik, M. & Slaby, O. Urinary microRNAs and their significance in prostate cancer diagnosis: A 5-Year update. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14133157 (2022).","journal-title":"Cancers (Basel)"},{"key":"32334_CR12","doi-asserted-by":"publisher","first-page":"1065757","DOI":"10.3389\/fgene.2023.1065757","volume":"14","author":"G Jain","year":"2023","unstructured":"Jain, G. et al. Urinary extracellular vesicles miRNA-A new era of prostate cancer biomarkers. Front. Genet. 14, 1065757. https:\/\/doi.org\/10.3389\/fgene.2023.1065757 (2023).","journal-title":"Front. Genet."},{"key":"32334_CR13","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.1038\/ncomms11906","volume":"7","author":"Y Kim","year":"2016","unstructured":"Kim, Y. et al. Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer. Nat. Commun. 7, 11906. https:\/\/doi.org\/10.1038\/ncomms11906 (2016).","journal-title":"Nat. Commun."},{"key":"32334_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.eururo.2018.08.019","volume":"74","author":"J McKiernan","year":"2018","unstructured":"McKiernan, J. et al. A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2\u201310ng\/ml at initial biopsy. Eur. Urol. 74, 731\u2013738. https:\/\/doi.org\/10.1016\/j.eururo.2018.08.019 (2018).","journal-title":"Eur. Urol."},{"key":"32334_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","volume":"70","author":"SA Tomlins","year":"2016","unstructured":"Tomlins, S. A. et al. Urine TMPRSS2:ERG plus PCA3 for individualized prostate cancer risk assessment. Eur. Urol. 70, 45\u201353. https:\/\/doi.org\/10.1016\/j.eururo.2015.04.039 (2016).","journal-title":"Eur. Urol."},{"key":"32334_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41391-022-00562-1","volume":"25","author":"WCH Visser","year":"2022","unstructured":"Visser, W. C. H. et al. Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer. Prostate Cancer Prostatic Dis. 25, 583\u2013589. https:\/\/doi.org\/10.1038\/s41391-022-00562-1 (2022).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"32334_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092102","author":"SP Connell","year":"2021","unstructured":"Connell, S. P. et al. Integration of urinary EN2 protein & cell-free RNA data in the development of a multivariable risk model for the detection of prostate cancer prior to biopsy. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers13092102 (2021).","journal-title":"Cancers (Basel)"},{"issue":"Suppl 3","key":"32334_CR18","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1007\/bf01643679","volume":"19","author":"J Frick","year":"1991","unstructured":"Frick, J. & Aulitzky, W. Physiology of the prostate. Infection 19(Suppl 3), S115-118. https:\/\/doi.org\/10.1007\/bf01643679 (1991).","journal-title":"Infection"},{"key":"32334_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41391-022-00537-2","volume":"25","author":"AP Alarcon-Zendejas","year":"2022","unstructured":"Alarcon-Zendejas, A. P. et al. The promising role of new molecular biomarkers in prostate cancer: From coding and non-coding genes to artificial intelligence approaches. Prostate Cancer Prostatic Dis. 25, 431\u2013443. https:\/\/doi.org\/10.1038\/s41391-022-00537-2 (2022).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"32334_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4274\/jus.galenos.2021.2021.0039","volume":"8","author":"K Karam\u0131k","year":"2021","unstructured":"Karam\u0131k, K. et al. Stage pT0 prostate cancer: A single-center study and literature review. J. Urol. Surg. 8, 255\u2013260. https:\/\/doi.org\/10.4274\/jus.galenos.2021.2021.0039 (2021).","journal-title":"J. Urol. Surg."},{"key":"32334_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/pas.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein, J. I. et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: Definition of grading patterns and proposal for a new grading system. Am. J. Surg. Pathol. 40, 244\u2013252. https:\/\/doi.org\/10.1097\/pas.0000000000000530 (2016).","journal-title":"Am. J. Surg. Pathol."},{"key":"32334_CR22","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinf. 12, 77. https:\/\/doi.org\/10.1186\/1471-2105-12-77 (2011).","journal-title":"BMC Bioinf."},{"key":"32334_CR23","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/(sici)1097-0258(20000515)19:9<1141::aid-sim479>3.0.co;2-f","volume":"19","author":"J Carpenter","year":"2000","unstructured":"Carpenter, J. & Bithell, J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Stat. Med. 19, 1141\u20131164. https:\/\/doi.org\/10.1002\/(sici)1097-0258(20000515)19:9%3c1141::aid-sim479%3e3.0.co;2-f (2000).","journal-title":"Stat. Med."},{"key":"32334_CR24","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1177\/25.7.894009","volume":"25","author":"IT Young","year":"1977","unstructured":"Young, I. T. Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J. Histochem. Cytochem. 25, 935\u2013941. https:\/\/doi.org\/10.1177\/25.7.894009 (1977).","journal-title":"J. Histochem. Cytochem."},{"key":"32334_CR25","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: Machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"32334_CR26","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.3715232","author":"J Reback","year":"2020","unstructured":"Reback, J. et al. Pandas-dev\/pandas: Pandas 1.0.3 (v1.0.3). Zenodo https:\/\/doi.org\/10.5281\/zenodo.3715232 (2020)."},{"key":"32334_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/1961189.1961199","volume":"2","author":"CC Chang","year":"2011","unstructured":"Chang, C. C. & Lin, C. J. LIBSVM: A library for support vector machines. ACM T. Intel. Syst. Tec. 2, 1\u201327. https:\/\/doi.org\/10.1145\/1961189.1961199 (2011).","journal-title":"ACM T. Intel. Syst. Tec."},{"key":"32334_CR28","doi-asserted-by":"crossref","unstructured":"Platt, J. C. in Advances in Large Margin Classifiers Ch. 5, 61\u201374 (MIT Press, 1999).","DOI":"10.7551\/mitpress\/1113.003.0008"},{"key":"32334_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324 (2001).","journal-title":"Mach. Learn."},{"key":"32334_CR30","unstructured":"Zhang, H. in International Florida Artificial Intelligence Research Society Conference (FLAIRS) 562\u2013567 (AAAI Press)."},{"key":"32334_CR31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1214\/aos\/1013203451","volume":"29","author":"JH Friedman","year":"2001","unstructured":"Friedman, J. H. Greedy function approximation: A gradient boosting machine. Ann. Stat. 29, 1189\u20131232. https:\/\/doi.org\/10.1214\/aos\/1013203451 (2001).","journal-title":"Ann. Stat."},{"key":"32334_CR32","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0167-9473(01)00065-2","volume":"38","author":"JH Friedman","year":"2002","unstructured":"Friedman, J. H. Stochastic gradient boosting. Comput. Stat. Data Anal. 38, 367\u2013378. https:\/\/doi.org\/10.1016\/S0167-9473(01)00065-2 (2002).","journal-title":"Comput. Stat. Data Anal."},{"key":"32334_CR33","unstructured":"Glorot, X. & Bengio, Y. in International Conference on Artificial Intelligence and Statistics (AISTATS) (eds Yee, W. T. & Mike, T.) 249\u2013256 (PMLR)."},{"key":"32334_CR34","unstructured":"He, K., Zhang, X., Ren, S. & Sun, J. in IEEE International Conference on Computer Vision (ICCV) 1026\u20131034 (IEEE)."},{"key":"32334_CR35","first-page":"1871","volume":"9","author":"RE Fan","year":"2008","unstructured":"Fan, R. E., Chang, K. W., Hsieh, C. J., Wang, X. R. & Lin, C. J. LIBLINEAR: A library for large linear classification. J. Mach. Learn. Res. 9, 1871\u20131874 (2008).","journal-title":"J. Mach. Learn. Res."},{"key":"32334_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256152","volume":"16","author":"C An","year":"2021","unstructured":"An, C. et al. Radiomics machine learning study with a small sample size: Single random training-test set split may lead to unreliable results. PLoS ONE 16, e0256152. https:\/\/doi.org\/10.1371\/journal.pone.0256152 (2021).","journal-title":"PLoS ONE"},{"key":"32334_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s41664-018-0068-2","volume":"2","author":"Y Xu","year":"2018","unstructured":"Xu, Y. & Goodacre, R. On splitting training and validation set: A comparative study of cross-validation, bootstrap and systematic sampling for estimating the generalization performance of supervised learning. J. Anal. Test 2, 249\u2013262. https:\/\/doi.org\/10.1007\/s41664-018-0068-2 (2018).","journal-title":"J. Anal. Test"},{"key":"32334_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1471-2105-7-91","volume":"7","author":"S Varma","year":"2006","unstructured":"Varma, S. & Simon, R. Bias in error estimation when using cross-validation for model selection. BMC Bioinform. 7, 91. https:\/\/doi.org\/10.1186\/1471-2105-7-91 (2006).","journal-title":"BMC Bioinform."},{"key":"32334_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21606-5","volume-title":"The Elements of Statistical Learning","author":"T Hastie","year":"2001","unstructured":"Hastie, T., Tibshirani, R. & Friedman, J. H. The Elements of Statistical Learning Vol. 1 (Springer, 2001)."},{"key":"32334_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1023\/A:1012487302797","volume":"46","author":"I Guyon","year":"2002","unstructured":"Guyon, I., Weston, J., Barnhill, S. & Vapnik, V. Gene selection for cancer classification using support vector machines. Mach. Learn. 46, 389\u2013422 (2002).","journal-title":"Mach. Learn."},{"key":"32334_CR41","doi-asserted-by":"publisher","first-page":"e220232","DOI":"10.1148\/ryai.220232","volume":"5","author":"TJ Bradshaw","year":"2023","unstructured":"Bradshaw, T. J., Huemann, Z., Hu, J. & Rahmim, A. A guide to cross-validation for artificial intelligence in medical imaging. Radiol. Artif. Intell. 5, e220232. https:\/\/doi.org\/10.1148\/ryai.220232 (2023).","journal-title":"Radiol. Artif. Intell."},{"key":"32334_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40104-017-0164-6","volume":"8","author":"H Cheng","year":"2017","unstructured":"Cheng, H., Garrick, D. J. & Fernando, R. L. Efficient strategies for leave-one-out cross validation for genomic best linear unbiased prediction. J. Anim. Sci. Biotechnol. 8, 38. https:\/\/doi.org\/10.1186\/s40104-017-0164-6 (2017).","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"32334_CR43","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1158\/1078-0432.CCR-07-0700","volume":"13","author":"D Hessels","year":"2007","unstructured":"Hessels, D. et al. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer. Clin. Cancer Res. 13, 5103\u20135108. https:\/\/doi.org\/10.1158\/1078-0432.CCR-07-0700 (2007).","journal-title":"Clin. Cancer Res."},{"key":"32334_CR44","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.euf.2017.02.018","volume":"4","author":"J Fredsoe","year":"2018","unstructured":"Fredsoe, J. et al. Diagnostic and prognostic microRNA biomarkers for prostate cancer in cell-free urine. Eur. Urol. Focus 4, 825\u2013833. https:\/\/doi.org\/10.1016\/j.euf.2017.02.018 (2018).","journal-title":"Eur. Urol. Focus"},{"key":"32334_CR45","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1158\/1078-0432.CCR-18-2849","volume":"25","author":"F Urabe","year":"2019","unstructured":"Urabe, F. et al. Large-scale circulating microRNA profiling for the liquid biopsy of prostate cancer. Clin. Cancer Res. 25, 3016\u20133025. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2849 (2019).","journal-title":"Clin. Cancer Res."},{"key":"32334_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10030541","author":"MM Ahsan","year":"2022","unstructured":"Ahsan, M. M., Luna, S. A. & Siddique, Z. Machine-learning-based disease diagnosis: A comprehensive review. Healthcare (Basel) https:\/\/doi.org\/10.3390\/healthcare10030541 (2022).","journal-title":"Healthcare (Basel)"},{"key":"32334_CR47","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s40001-025-02680-7","volume":"30","author":"H Sadr","year":"2025","unstructured":"Sadr, H. et al. Unveiling the potential of artificial intelligence in revolutionizing disease diagnosis and prediction: A comprehensive review of machine learning and deep learning approaches. Eur. J. Med. Res. 30, 418. https:\/\/doi.org\/10.1186\/s40001-025-02680-7 (2025).","journal-title":"Eur. J. Med. Res."},{"key":"32334_CR48","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1038\/s41598-024-56706-x","volume":"14","author":"O Rainio","year":"2024","unstructured":"Rainio, O., Teuho, J. & Kl\u00e9n, R. Evaluation metrics and statistical tests for machine learning. Sci. Rep. 14, 6086. https:\/\/doi.org\/10.1038\/s41598-024-56706-x (2024).","journal-title":"Sci. Rep."},{"key":"32334_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41746-023-00832-9","volume":"6","author":"AAH de Hond","year":"2023","unstructured":"de Hond, A. A. H. et al. Perspectives on validation of clinical predictive algorithms. NPJ Digit. Med. 6, 86. https:\/\/doi.org\/10.1038\/s41746-023-00832-9 (2023).","journal-title":"NPJ Digit. Med."},{"key":"32334_CR50","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement. BMJ 350, g7594. https:\/\/doi.org\/10.1136\/bmj.g7594 (2015).","journal-title":"BMJ"},{"key":"32334_CR51","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2281","volume":"375","author":"CL Andaur Navarro","year":"2021","unstructured":"Andaur Navarro, C. L. et al. Risk of bias in studies on prediction models developed using supervised machine learning techniques: systematic review. BMJ 375, n2281. https:\/\/doi.org\/10.1136\/bmj.n2281 (2021).","journal-title":"BMJ"},{"key":"32334_CR52","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/s0302-2838(03)00201-x","volume":"44","author":"D Hessels","year":"2003","unstructured":"Hessels, D. et al. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur. Urol. 44, 8\u201316. https:\/\/doi.org\/10.1016\/s0302-2838(03)00201-x (2003).","journal-title":"Eur. Urol."},{"key":"32334_CR53","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.eururo.2010.11.026","volume":"59","author":"PN Nguyen","year":"2011","unstructured":"Nguyen, P. N. et al. A panel of TMPRSS2:ERG fusion transcript markers for urine-based prostate cancer detection with high specificity and sensitivity. Eur. Urol. 59, 407\u2013414. https:\/\/doi.org\/10.1016\/j.eururo.2010.11.026 (2011).","journal-title":"Eur. Urol."},{"key":"32334_CR54","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1158\/0008-5472.CAN-07-3224","volume":"68","author":"B Laxman","year":"2008","unstructured":"Laxman, B. et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res. 68, 645\u2013649. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-3224 (2008).","journal-title":"Cancer Res."},{"key":"32334_CR55","doi-asserted-by":"publisher","DOI":"10.2196\/49023","volume":"2","author":"D Wilimitis","year":"2023","unstructured":"Wilimitis, D. & Walsh, C. G. Practical considerations and applied examples of cross-validation for model development and evaluation in health care: Tutorial. JMIR AI 2, e49023. https:\/\/doi.org\/10.2196\/49023 (2023).","journal-title":"JMIR AI"},{"key":"32334_CR56","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/ijcp.12883","volume":"70","author":"T Ross","year":"2016","unstructured":"Ross, T., Ahmed, K., Raison, N., Challacombe, B. & Dasgupta, P. Clarifying the PSA grey zone: The management of patients with a borderline PSA. Int. J. Clin. Pract. 70, 950\u2013959. https:\/\/doi.org\/10.1111\/ijcp.12883 (2016).","journal-title":"Int. J. Clin. Pract."},{"key":"32334_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","volume":"11","author":"H Schwarzenbach","year":"2014","unstructured":"Schwarzenbach, H., Nishida, N., Calin, G. A. & Pantel, K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat. Rev. Clin. Oncol. 11, 145\u2013156. https:\/\/doi.org\/10.1038\/nrclinonc.2014.5 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"32334_CR58","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41416-021-01677-3","volume":"126","author":"S Rana","year":"2022","unstructured":"Rana, S., Valbuena, G. N., Curry, E., Bevan, C. L. & Keun, H. C. MicroRNAs as biomarkers for prostate cancer prognosis: A systematic review and a systematic reanalysis of public data. Br. J. Cancer 126, 502\u2013513. https:\/\/doi.org\/10.1038\/s41416-021-01677-3 (2022).","journal-title":"Br. J. Cancer"},{"key":"32334_CR59","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4103\/jcrt.jcrt_1469_22","volume":"20","author":"H Palanisamy","year":"2024","unstructured":"Palanisamy, H., Manoharan, J. P. & Vidyalakshmi, S. Prognostic microRNAs as biomarkers for prostate cancer. J. Cancer Res. Ther. 20, 297\u2013303. https:\/\/doi.org\/10.4103\/jcrt.jcrt_1469_22 (2024).","journal-title":"J. Cancer Res. Ther."},{"key":"32334_CR60","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.juro.2018.03.127","volume":"200","author":"DP Guo","year":"2018","unstructured":"Guo, D. P. et al. The research implications of prostate specific antigen registry errors: Data from the veterans health administration. J. Urol. 200, 541\u2013548. https:\/\/doi.org\/10.1016\/j.juro.2018.03.127 (2018).","journal-title":"J. Urol."},{"key":"32334_CR61","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.urolonc.2011.04.001","volume":"31","author":"SS Salami","year":"2013","unstructured":"Salami, S. S. et al. Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer. Urol. Oncol. 31, 566\u2013571. https:\/\/doi.org\/10.1016\/j.urolonc.2011.04.001 (2013).","journal-title":"Urol. Oncol."},{"key":"32334_CR62","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.urolonc.2020.02.018","volume":"39","author":"MF Becerra","year":"2021","unstructured":"Becerra, M. F., Atluri, V. S., Bhattu, A. S. & Punnen, S. Serum and urine biomarkers for detecting clinically significant prostate cancer. Urol. Oncol. 39, 686\u2013690. https:\/\/doi.org\/10.1016\/j.urolonc.2020.02.018 (2021).","journal-title":"Urol. Oncol."},{"key":"32334_CR63","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.eururo.2004.06.004","volume":"46","author":"M Tinzl","year":"2004","unstructured":"Tinzl, M., Marberger, M., Horvath, S. & Chypre, C. DD3PCA3 RNA analysis in urine\u2013A new perspective for detecting prostate cancer. Eur. Urol. 46, 182\u2013186. https:\/\/doi.org\/10.1016\/j.eururo.2004.06.004 (2004).","journal-title":"Eur. Urol."},{"key":"32334_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-0716-1354-2_6","volume":"2292","author":"E Bandini","year":"2021","unstructured":"Bandini, E. Urinary microRNA and mRNA in tumors. Methods Mol. Biol. 2292, 57\u201372. https:\/\/doi.org\/10.1007\/978-1-0716-1354-2_6 (2021).","journal-title":"Methods Mol. Biol."},{"key":"32334_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.eururo.2014.07.035","volume":"67","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur. Urol. 67, 33\u201341. https:\/\/doi.org\/10.1016\/j.eururo.2014.07.035 (2015).","journal-title":"Eur. Urol."},{"key":"32334_CR66","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/bjc.2011.595","volume":"106","author":"RJ Bryant","year":"2012","unstructured":"Bryant, R. J. et al. Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 106, 768\u2013774. https:\/\/doi.org\/10.1038\/bjc.2011.595 (2012).","journal-title":"Br. J. Cancer"},{"key":"32334_CR67","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons, K. G. et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): Explanation and elaboration. Ann. Intern. Med. 162, W1-73. https:\/\/doi.org\/10.7326\/M14-0698 (2015).","journal-title":"Ann. Intern. Med."},{"key":"32334_CR68","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-074819","volume":"384","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. Evaluation of clinical prediction models (part 1): From development to external validation. BMJ 384, e074819. https:\/\/doi.org\/10.1136\/bmj-2023-074819 (2024).","journal-title":"BMJ"},{"key":"32334_CR69","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.euros.2022.04.001","volume":"40","author":"MJ Hagens","year":"2022","unstructured":"Hagens, M. J. et al. Diagnostic performance of a magnetic resonance imaging-directed targeted plus regional biopsy approach in prostate cancer diagnosis: A systematic review and meta-analysis. Eur. Urol. Open Sci. 40, 95\u2013103. https:\/\/doi.org\/10.1016\/j.euros.2022.04.001 (2022).","journal-title":"Eur. Urol. Open Sci."},{"key":"32334_CR70","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-18-3378","volume":"25","author":"E Kawakami","year":"2019","unstructured":"Kawakami, E. et al. Application of artificial intelligence for preoperative diagnostic and prognostic prediction in epithelial ovarian cancer based on blood biomarkers. Clin. Cancer Res. 25, 3006\u20133015. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3378 (2019).","journal-title":"Clin. Cancer Res."},{"key":"32334_CR71","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.eururo.2009.10.029","volume":"57","author":"JW Catto","year":"2010","unstructured":"Catto, J. W. et al. The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression. Eur. Urol. 57, 398\u2013406. https:\/\/doi.org\/10.1016\/j.eururo.2009.10.029 (2010).","journal-title":"Eur. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32334-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32334-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32334-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:14:35Z","timestamp":1769213675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32334-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32334"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32334-x","relation":{"references":[{"id-type":"doi","id":"10.5281\/zenodo.3715232","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"assertion":[{"value":"22 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.H., K.Y.C. and J.M.K. are the named inventors on a provisional patent application related to the technologies developed in this work. H.G., J.W. K., Y.K., B.L., M.K.W., and C.S.K. declare no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. The experimental plan was approved by the Institutional Review Board of Asan Medical Center (Seoul, Republic of Korea\/IRB No. 2019-1312). Written informed consent was obtained from all patients. The protocols for the human urine assay were approved by the Ethics Committee of the Asan Medical Center, and the human urine assays were performed in accordance with the approved guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"2445"}}